<DOC>
	<DOCNO>NCT02567539</DOCNO>
	<brief_summary>The study aim evaluate efficacy safety re-irradiation patient recurrent high grade glioma treatment .</brief_summary>
	<brief_title>Hypofractionated Stereotactic Radiotherapy Patients With Recurrent High Grade Glioma</brief_title>
	<detailed_description>Investigators design study re-irradiation single radiosurgery hypofractionated intensity modulate radiation therapy ( IMRT ) without temozolomide . Objective study evaluate efficacy safety re-irradiation patient recurrent high grade glioma treatment .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>Age &gt; 18 year Karnosky performance status ( KPS ) ≥70 Patients age &gt; 70 year KPS ≥80 Histopathologically confirm grade IIIIV glioma Estimated survival ≥ 3 month Any Tumor volume Unifocal tumor Interval time previous radiotherapy ≥ 6mesi Normal liver , Kidney bone marrow function Written inform consent KPS &lt; 70 Multifocal tumor Other primary cancer Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>